BioReFine has developed a unique endovascular annuloplasty remodeling system, free of implants, designed for the repair of the mitral and tricuspid heart valves.

This innovative technology addresses a significant unmet need, providing treatment to a vast population currently ineligible for care due to the high risks associated with open-heart surgery.

The implant-free solution offers numerous advantages: it enables significantly easier regulation, utilizes a standard endovascular approach, ensures a safe and repeatable procedure, and does not hinder additional or ancillary treatments.